Northwire Canada EditionSaturday, October 17, 2026
Northwire
⌕
GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0% GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0%
Financings

Rocket Doctor arranges $3-million private placement

AIDR · Price

Executive Summary

  • Rocket Doctor AI Inc. announced a non-brokered private placement under the Listed Issuer Financing Exemption (LIFE) to raise a minimum of approximately $3 million in gross proceeds.
  • The offering consists of 4,285,715 units priced at $0.70 per unit, with each unit comprising one common share and one warrant exercisable at $0.85 per share for a 12-month term.
  • Net proceeds will fund digital marketing, customer acquisition, R&D, operating expenses, and general working capital, with closing expected on or about January 19, 2026, subject to CSE approval and minimum subscription thresholds.

Key Details

  • Structure & Exemption: Non-brokered private placement completed under the Listed Issuer Financing Exemption (LIFE) per Part 5A of National Instrument 45-106.
  • Units Offered: Minimum of 4,285,715 units.
  • Price: $0.70 per unit.
  • Gross Proceeds: Minimum of approximately $3,000,000.
  • Unit Composition: Each unit consists of one common share and one common share purchase warrant.
  • Warrant Terms: Each warrant entitles the holder to purchase one common share at an exercise price of $0.85 per share for a period of 12 months following the closing date.
  • Hold Period: Units issued under the LIFE exemption are not subject to a statutory hold period under Canadian securities laws.
  • Finder’s Fee & Compensation: Up to 8% of aggregate gross proceeds payable as a finder’s fee, plus non-transferable warrants exercisable at $0.85 per share equal to 8% of the number of units issued, exercisable for 12 months from closing.
  • Use of Proceeds: Digital marketing, customer acquisition, operating and administrative expenses (including salaries), research and development, and general working capital.
  • Closing Date: On or about January 19, 2026.
  • Conditions Precedent: Receipt of minimum subscriptions totaling $3,000,000 and all necessary regulatory approvals, including Canadian Securities Exchange (CSE) approval.
  • Jurisdiction: Available to purchasers resident in all Canadian provinces except Quebec.
Read the original news release →

More from Rocket Doctor AI Inc